Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Climo

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|January 4, 2001
Staphylococcus aureus bacteremia--consider the sourceG L Archer, M W Climo
Antimicrobial Agents and Chemotherapy|October 1, 1994
Antimicrobial susceptibility of coagulase-negative staphylococciG L Archer, M W Climo
Infection Control and Hospital Epidemiology|July 1, 1997
An outbreak of Pseudomonas aeruginosa related to contaminated urodynamic equipmentM W Climo, A Pastor, E S Wong
Antimicrobial Agents and Chemotherapy|April 17, 2001
Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureusM W Climo, K Ehlert, G L Archer
Antimicrobial Agents and Chemotherapy|April 4, 1998
Determination of the chromosomal relationship between mecA and gyrA in methicillin-resistant coagulase-negative staphylococciP D Fey, M W Climo, G L Archer
Journal of Bacteriology|August 1, 1996
Identification and characterization of the origin of conjugative transfer (oriT) and a gene (nes) encoding a single-stranded endonuclease on the staphylococcal plasmid pGO1M W Climo, V K Sharma, G L Archer
Antimicrobial Agents and Chemotherapy|July 2, 1999
Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycinM W Climo, R L Patron, G L Archer
Antimicrobial Agents and Chemotherapy|July 2, 1999
Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycinR L Patron, M W Climo, B P Goldstein, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Role of penicillin-binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureusJ E Finan, G L Archer, M J Pucci, et al.
Antimicrobial Agents and Chemotherapy|June 13, 1998
Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditisM W Climo, R L Patron, B P Goldstein, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|January 4, 2001
Staphylococcus aureus bacteremia--consider the sourceG L Archer, M W Climo
Antimicrobial Agents and Chemotherapy|October 1, 1994
Antimicrobial susceptibility of coagulase-negative staphylococciG L Archer, M W Climo
Infection Control and Hospital Epidemiology|July 1, 1997
An outbreak of Pseudomonas aeruginosa related to contaminated urodynamic equipmentM W Climo, A Pastor, E S Wong
Antimicrobial Agents and Chemotherapy|April 17, 2001
Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureusM W Climo, K Ehlert, G L Archer
Antimicrobial Agents and Chemotherapy|April 4, 1998
Determination of the chromosomal relationship between mecA and gyrA in methicillin-resistant coagulase-negative staphylococciP D Fey, M W Climo, G L Archer
Journal of Bacteriology|August 1, 1996
Identification and characterization of the origin of conjugative transfer (oriT) and a gene (nes) encoding a single-stranded endonuclease on the staphylococcal plasmid pGO1M W Climo, V K Sharma, G L Archer
Antimicrobial Agents and Chemotherapy|July 2, 1999
Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycinM W Climo, R L Patron, G L Archer
Antimicrobial Agents and Chemotherapy|July 2, 1999
Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycinR L Patron, M W Climo, B P Goldstein, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2001
Role of penicillin-binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureusJ E Finan, G L Archer, M J Pucci, et al.
Antimicrobial Agents and Chemotherapy|June 13, 1998
Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditisM W Climo, R L Patron, B P Goldstein, et al.
Pageof 2